DNA logo

DNA
Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

12,788
Mkt Cap
$486.54M
Volume
1.13M
52W High
$17.58
52W Low
$5.00
PE Ratio
-1.29
DNA Fundamentals
Price
$8.03
Prev Close
$8.00
Open
$7.67
50D MA
$12.28
Beta
2.56
Avg. Volume
1.58M
EPS (Annual)
-$10.54
P/B
0.77
Rev/Employee
$272,233.81
Loading...
Loading...
News
all
press releases
Ginkgo Bioworks (NYSE:DNA) Releases Earnings Results, Misses Expectations By $0.21 EPS
Ginkgo Bioworks (NYSE:DNA - Get Free Report) released its earnings results on Thursday. The company reported ($1.45) EPS for the quarter, missing the consensus estimate of ($1.24) by ($0.21). Ginkgo...
MarketBeat·7d ago
News Placeholder
More News
News Placeholder
Ginkgo Bioworks (NYSE:DNA) Shares Gap Down After Earnings Miss
Ginkgo Bioworks (NYSE:DNA) Shares Gap Down on Disappointing Earnings...
MarketBeat·8d ago
News Placeholder
Ginkgo Bioworks Holdings Q3 Loss Widens
(RTTNews) - Ginkgo Bioworks Holdings, Inc. (DNA) on Thursday reported third-quarter net loss of $80.76 million or $1.45 per share, compared to $56.40 million or $1.08 per share in the comparable...
Nasdaq News: Markets·10d ago
News Placeholder
Ginkgo Bioworks Reports Third Quarter 2025 Financial Results
Ginkgo Bioworks Reports Third Quarter 2025 Financial Results Ginkgo Bioworks Reports Third Quarter 2025 Financial Results PR Newswire BOSTON, Nov. 6, 2025 Ginkgo provides an update on its third...
PR Newswire·10d ago
News Placeholder
Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture
Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership...
PR Newswire·16d ago
News Placeholder
Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation
Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation PR Newswire BOSTON, Oct. 30, 2025 Presentation and...
PR Newswire·17d ago
News Placeholder
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts
Ginkgo Bioworks Holdings, Inc. (DNA) concluded the recent trading session at $12.74, signifying a -4.85% move from its prior day's close.
Zacks·19d ago
News Placeholder
Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program
Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program Ginkgo Bioworks in Partnership with STRM.BIO...
PR Newswire·24d ago
News Placeholder
Ginkgo Bioworks Holdings, Inc. (DNA) Suffers a Larger Drop Than the General Market: Key Insights
In the latest trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $12.78, marking a -2.67% move from the previous day.
Zacks·25d ago
News Placeholder
The Institute for Follicular Lymphoma Innovation (IFLI) Appoints Innovative Leaders Mehrdad Mobasher, M.D., M.P.H., and Carol O'Hear, M.D., Ph.D., as Executive Partners
The Institute for Follicular Lymphoma Innovation (IFLI) Appoints Innovative Leaders Mehrdad Mobasher, M.D., M.P.H., and Carol O'Hear, M.D., Ph.D., as Executive Partners The Institute for Follicular...
PR Newswire·26d ago

Latest DNA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.